Jefferies Starts Molina Healthcare (MOH) at Hold
Get Alerts MOH Hot Sheet
Price: $212.43 +3.27%
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies initiates coverage on Molina Healthcare (NYSE: MOH) with a Hold. PT $37.00.
The firm comments, "The California Duals present a very large opportunity, but the stock has run up 51% YTD and trades above Medicaid peers. Additionally, our granular analysis shows MOH stands to benefit less than peers from the robust Medicaid RFP pipeline. The company's below average profitability, Missouri RFP loss, and elevated risk profile are also cautionary factors."
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $33.44 yesterday.
The firm comments, "The California Duals present a very large opportunity, but the stock has run up 51% YTD and trades above Medicaid peers. Additionally, our granular analysis shows MOH stands to benefit less than peers from the robust Medicaid RFP pipeline. The company's below average profitability, Missouri RFP loss, and elevated risk profile are also cautionary factors."
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $33.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share